Filler Migration — What Went Wrong and How It Is Fixed

Filler does not wander on its own. Migration is almost always something that was done to the tissue, not something the product decided to do — too much volume, the wrong plane, the wrong material, or a top-up given before the last round had settled. The fix is rarely more filler.

What Migration Actually Is

Migration means hyaluronic acid sitting outside the compartment it was intended for. In the lip it appears as a pale shelf above the vermilion border, giving the upper lip a stepped profile and a shadow that was not there before. In the infraorbital region it appears as a bluish, doughy fullness that extends further onto the cheek than any anatomical hollow does. On the nose it appears as a widening of the dorsum.

The material has not dissolved and re-formed elsewhere. It has been displaced — along the path of least resistance through loose areolar tissue and along fascial planes, pushed by the pressure of injection, by muscle movement, and by the simple fact that a compartment which is already full has nowhere to put anything more.

This matters because migration is often described to patients as an unavoidable property of a product, which places the problem outside anyone's control. It is more accurate, and more useful, to treat it as a technical outcome with identifiable causes. The signs of migrated filler are distinct from those of simple over-correction, and the two are managed differently.

Cause One — More Volume Than The Compartment Holds

Every region of the face has a finite capacity before the tissue stops accommodating and starts redirecting. The lip is the clearest example: the vermilion body can hold a modest volume before pressure forces product upward over the border into the cutaneous lip, where it has no business being and where it is immediately visible in profile.

Capacity is individual. It depends on skin thickness, the tightness of the fibrous attachments in the region, and how much product is already in place from previous years. A volume that sits perfectly in one patient exceeds the compartment in another, which is why a treatment plan that specifies a quantity before the examination is working backwards.

The pattern that produces this is familiar — a patient who wanted a visible change, a request to use the full syringe, and a result that looked reasonable at two weeks and stepped at six months. Restraint at the point of injection is the only prevention, and it is the principle that governs lip enhancement here.

Cause Two — The Wrong Plane

Depth is not a matter of preference. Each region has a plane in which product stays where it is put, held by the surrounding structures, and planes in which it does not. Product placed too superficially in thin skin is visible as a ridge and tracks along the dermis. Product placed into loose areolar tissue rather than onto periosteum spreads across a wide area under the pressure of ordinary facial movement.

The infraorbital region is the least forgiving. Beneath the orbicularis and directly on bone, a small volume stays put. Above the muscle, in a region with almost no subcutaneous fat and a well-developed lymphatic drainage that is easily obstructed, the same volume spreads, holds fluid and produces the bluish swelling patients describe as permanent eye bags after filler.

This is why tear trough treatment is a technically demanding procedure rather than a routine one, and why the correct response to a poor result there is usually removal rather than adjustment. Adding product to blend an incorrectly placed deposit places more material into a plane that already demonstrated it cannot hold it.

Cause Three — The Wrong Product For The Region

Hyaluronic acid fillers are not interchangeable. They differ in how strongly they resist deformation, how much water they attract, and how readily they spread through tissue. A firm, highly cohesive product is designed to project against pressure and belongs on bone in regions that need structure. A soft, low-viscosity product is designed to integrate into thin, mobile tissue.

Using them the wrong way round produces predictable problems. A structural product in the lip feels firm, sits as a discrete mass and is visible in animation. A soft, highly hydrophilic product under the eye draws fluid into a region that already struggles to drain it, and the fullness that develops weeks later is often mistaken for migration when it is water.

Product selection follows the region and the tissue, not the other way round. Where a face needs structural support across a wide area, a collagen-stimulating product may be the better instrument than any hyaluronic acid, and that is a decision made at assessment rather than at the point of injection.

Cause Four — Topping Up Before It Settled

Hyaluronic acid integrates into tissue over weeks. It also attracts water, so the appearance at two weeks includes a component of swelling that will resolve, and the appearance at three months is the true result. A top-up performed at four weeks is therefore layered onto a region whose real volume has not yet been established.

Done repeatedly over years, this accumulates. Product persists longer than the marketing intervals suggest, particularly in low-movement areas, so a patient treated every six months may be carrying several years of material without ever having seen the face empty. Each round appears to do less, which prompts more, and the compartments progressively lose their definition.

The endpoint is the flattened, heavy midface with lost angles that patients recognise before they can name — pillow face. It is almost never the result of one bad treatment. It is the result of a sensible-looking interval applied for too long without a baseline reassessment.

The Correction — Dissolve, Settle, Reassess, Rebuild

The first step is removal. Hyaluronidase breaks down hyaluronic acid filler, and in a migrated or over-filled region the target is usually all of it rather than a portion, because partial dissolving leaves an unknown quantity behind and the next decision is then made blind. This is uncomfortable for a patient who is attached to the volume, and it is still the right sequence.

The second step is waiting. Tissue that has been stretched needs time to recoil, and the appearance immediately after dissolving is misleading — hollower than the true baseline, which tempts an immediate refill and restarts the cycle. Several weeks of doing nothing is a clinical instruction, not a delay.

Only then is the face reassessed, on its actual anatomy rather than on the history of what has been put into it. Rebuilding is conservative, structural, and placed where volume was genuinely lost. Filler correction and volume restoration are two separate appointments for a reason, and compressing them is how the original problem was created.

What Dissolving Does And Does Not Do

Hyaluronidase acts only on hyaluronic acid. It does nothing to biostimulatory products, to permanent materials, or to the tissue changes those may have produced — which is one of the substantive reasons to understand what was injected before consenting to it. Where the previous product is unknown and non-HA, the options narrow considerably and the honest answer may be that time is the only treatment.

It can also reduce native hyaluronic acid in the treated region temporarily, and skin that has been stretched around a large deposit for years may not fully recoil. In an older patient with reduced elasticity, some laxity remains after removal and requires tightening rather than refilling. That is disclosed before the syringe, not afterwards.

The procedure itself carries a risk of allergic reaction and is not undertaken casually. But where product is sitting in the wrong place, removal is the only intervention that returns the face to a state in which a correct decision can be made. Everything else is an adjustment layered on top of an error, and the correction of over-filled faces consistently starts by going backwards before going forwards.